Loading…
Based on limited metadata, this warning letter was issued to TAKA USA, INC. (operating as Cosmetic Innovations) on July 29, 2020, regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The FDA's enforcement action indicates regulatory concerns within the drug product category, though the specific issuing office and violation details are not available in this metadata summary.